| P50 | author | Tobias Neff | Q41942572 |
| P2093 | author name string | S A Armstrong | |
| P2860 | cites work | Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains | Q21092474 |
| | A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells | Q22066257 |
| | Regulation of chromatin structure by site-specific histone H3 methyltransferases | Q24290115 |
| | Somatic mutations in the neurofibromatosis 1 gene in human tumors | Q24293243 |
| | The Polycomb group protein EZH2 directly controls DNA methylation | Q24299020 |
| | Role of histone H2A ubiquitination in Polycomb silencing | Q24305090 |
| | Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF | Q24305335 |
| | Role of the polycomb repressive complex 2 in acute promyelocytic leukemia | Q24309258 |
| | Core transcriptional regulatory circuitry in human embryonic stem cells | Q24322016 |
| | Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 | Q24336747 |
| | Global and Hox-specific roles for the MLL1 methyltransferase | Q24529562 |
| | The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor | Q40031496 |
| | Protein arginine-methyltransferase-dependent oncogenesis | Q40077054 |
| | The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling | Q40202913 |
| | Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. | Q40252270 |
| | Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia | Q40267029 |
| | The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote | Q40903819 |
| | Di-methyl H4 lysine 20 targets the checkpoint protein Crb2 to sites of DNA damage | Q41915130 |
| | Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment | Q44155422 |
| | Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines | Q44317132 |
| | Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation | Q44364520 |
| | 5-Methylcytosine as an Endogenous Mutagen in the Human LDL Receptor and p53 Genes | Q45943296 |
| | NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. | Q46277256 |
| | Spatial distribution of di- and tri-methyl lysine 36 of histone H3 at active genes | Q46370672 |
| | Oncogene-induced senescence as an initial barrier in lymphoma development | Q46634165 |
| | Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells | Q46678698 |
| | Gene expression profiling of pediatric acute myelogenous leukemia | Q47266175 |
| | BMI-1 is highly expressed in M0-subtype acute myeloid leukemia | Q53355262 |
| | Reprogramming the histone code | Q53574922 |
| | Histone deacetylase inhibitors in cancer therapy | Q57272462 |
| | Bmi-1over-expression plays a secondary role in chronic myeloid leukemia transformation | Q63199326 |
| | Hypomethylation of DNA from benign and malignant human colon neoplasms | Q69381419 |
| | Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5 | Q78570048 |
| | Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia | Q80008526 |
| | Chromatin compaction by a polycomb group protein complex | Q81067457 |
| | Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis | Q81208548 |
| | Association between BMI-1 expression, acute graft-versus-host disease, and outcome following allogeneic stem cell transplantation from HLA-identical siblings in chronic myeloid leukemia | Q81484529 |
| | The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin | Q81691719 |
| | Polycomb group proteins Ezh2 and Rnf2 direct genomic contraction and imprinted repression in early mouse embryos | Q82264671 |
| | A trithorax-group complex purified from Saccharomyces cerevisiae is required for methylation of histone H3 | Q24531253 |
| | The Saccharomyces cerevisiae Set1 complex includes an Ash2 homologue and methylates histone 3 lysine 4 | Q24536072 |
| | Set2 is a nucleosomal histone H3-selective methyltransferase that mediates transcriptional repression. | Q24537640 |
| | Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias | Q24559974 |
| | A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin | Q24561636 |
| | DNA methylation profiling of human chromosomes 6, 20 and 22 | Q24607522 |
| | Genome-scale DNA methylation maps of pluripotent and differentiated cells | Q24621431 |
| | ACETYLATION AND METHYLATION OF HISTONES AND THEIR POSSIBLE ROLE IN THE REGULATION OF RNA SYNTHESIS | Q24629431 |
| | Genome-wide maps of chromatin state in pluripotent and lineage-committed cells | Q24632506 |
| | DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells | Q24655388 |
| | Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs | Q24673619 |
| | Lysine methylation within the globular domain of histone H3 by Dot1 is important for telomeric silencing and Sir protein association | Q24675122 |
| | MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein | Q24679773 |
| | Structure of HP1 chromodomain bound to a lysine 9-methylated histone H3 tail | Q27638012 |
| | Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by Polycomb and HP1 chromodomains | Q27641772 |
| | Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins | Q27860456 |
| | High-resolution profiling of histone methylations in the human genome | Q27860906 |
| | A bivalent chromatin structure marks key developmental genes in embryonic stem cells | Q27860977 |
| | Chromatin modifications and their function | Q27861067 |
| | COMPASS: a complex of proteins associated with a trithorax-related SET domain protein | Q27931344 |
| | Promoter-specific binding of Rap1 revealed by genome-wide maps of protein-DNA association | Q27933908 |
| | hDOT1L links histone methylation to leukemogenesis | Q27935809 |
| | COMPASS, a histone H3 (Lysine 4) methyltransferase required for telomeric silencing of gene expression | Q27938795 |
| | Genome-wide location and function of DNA binding proteins | Q28131765 |
| | Targeted mutation of the DNA methyltransferase gene results in embryonic lethality | Q28131773 |
| | Role of histone H3 lysine 27 methylation in Polycomb-group silencing | Q28131795 |
| | Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails | Q28216534 |
| | Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor | Q28217975 |
| | Control of developmental regulators by Polycomb in human embryonic stem cells | Q28235841 |
| | The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3 | Q28242719 |
| | Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug | Q28282479 |
| | The Eukaryotic Genome as an RNA Machine | Q28315740 |
| | Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies | Q36129533 |
| | Assembly of variant histones into chromatin | Q36280301 |
| | Cell cycle-specific reactivation of an inactive X-chromosome locus by 5-azadeoxycytidine | Q36282892 |
| | High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer | Q36423456 |
| | A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification | Q36447915 |
| | Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse | Q36835063 |
| | H3K79 methylation profiles define murine and human MLL-AF4 leukemias | Q36991857 |
| | Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia | Q37023597 |
| | Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation | Q37449132 |
| | MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia | Q38294261 |
| | Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia | Q38303652 |
| | The retinoblastoma binding protein RBP2 is an H3K4 demethylase | Q38304373 |
| | Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells | Q39840959 |
| | Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia. | Q39975102 |
| | H2AZ is enriched at polycomb complex target genes in ES cells and is necessary for lineage commitment | Q39989822 |
| | Histone H3 lysine 4 methylation is mediated by Set1 and required for cell growth and rDNA silencing in Saccharomyces cerevisiae | Q28343956 |
| | Polycomb group proteins Ring1A/B link ubiquitylation of histone H2A to heritable gene silencing and X inactivation | Q28505166 |
| | Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex | Q28505248 |
| | NSD1 is essential for early post-implantation development and has a catalytically active SET domain | Q28593118 |
| | Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation | Q28593817 |
| | MLL targets SET domain methyltransferase activity to Hox gene promoters | Q28609771 |
| | PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin | Q28647369 |
| | A chromatin landmark and transcription initiation at most promoters in human cells | Q29547180 |
| | Polycomb complexes repress developmental regulators in murine embryonic stem cells | Q29547274 |
| | Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome | Q29547359 |
| | Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation | Q29614333 |
| | Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins | Q29614507 |
| | Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions | Q29614512 |
| | Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly | Q29614718 |
| | Dot1p modulates silencing in yeast by methylation of the nucleosome core | Q29614855 |
| | Histone methyltransferase activity of a Drosophila Polycomb group repressor complex | Q29615394 |
| | Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease | Q29617086 |
| | DNA methylation landscapes: provocative insights from epigenomics | Q29617144 |
| | The epigenetic progenitor origin of human cancer | Q29617486 |
| | ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation | Q29618299 |
| | ATP-dependent nucleosome remodeling | Q29618979 |
| | Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression | Q29619380 |
| | Epigenetic stem cell signature in cancer | Q29622897 |
| | Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer | Q29622925 |
| | Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase | Q33272939 |
| | An integrative genomic and epigenomic approach for the study of transcriptional regulation | Q33325492 |
| | Purification and functional characterization of SET8, a nucleosomal histone H4-lysine 20-specific methyltransferase | Q34139275 |
| | Dot1a-AF9 complex mediates histone H3 Lys-79 hypermethylation and repression of ENaCalpha in an aldosterone-sensitive manner | Q34462951 |
| | Evidence for an instructive mechanism of de novo methylation in cancer cells. | Q34489258 |
| | Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells | Q34619655 |
| | Trithorax-group protein ASH1 methylates histone H3 lysine 36. | Q34633633 |
| | DNA methylation in health, disease, and cancer | Q34653521 |
| | Epigenetics: a historical overview | Q34713017 |
| | DNA hypomethylation leads to elevated mutation rates | Q34752442 |
| | MicroRNAs in normal and malignant hematopoiesis | Q34785149 |
| | Demethylating agents in myeloid malignancies | Q34847863 |
| | Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay | Q35720707 |
| | Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications | Q35734509 |
| | Epigenetic characterization of hematopoietic stem cell differentiation using miniChIP and bisulfite sequencing analysis | Q35901787 |
| P433 | issue | 7 | |
| P921 | main subject | leukemia | Q29496 |
| P304 | page(s) | 1243-1251 | |
| P577 | publication date | 2009-03-26 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Leukemia | Q6534498 |
| P1476 | title | Chromatin maps, histone modifications and leukemia | |
| P478 | volume | 23 | |